Table 5 Transcription factors and targets with significant overall survival associations in cohort GSE22762
GENE | Regulation in poor prognoses | P-value | GENE | Regulation in poor prognoses | P-value |
|---|---|---|---|---|---|
NRIP1 | Down | 1.89E-10 | BCL7A | Up | 9.31E-04 |
TCF7 | Down | 1.67E-06 | SNED1 | Down | 1.09E-03 |
PDE8A | Down | 7.10E-06 | DOK2 | Down | 1.10E-03 |
CD247 | Down | 7.67E-06 | ARSD | Up | 1.14E-03 |
SORL1 | Down | 4.27E-05 | RASGRP1 | Down | 1.27E-03 |
ATOX1 | Up | 5.07E-05 | LHFPL2 | Down | 1.54E-03 |
P2RX1 | Up | 6.37E-05 | EGR3 | Down | 1.65E-03 |
NME1 | Up | 8.27E-05 | HLADMA | Up | 1.85E-03 |
NMB | Up | 1.12E-04 | LRMP | Up | 1.96E-03 |
GMDS | Up | 1.17E-04 | DIP2C | Up | 2.06E-03 |
IL2RB | Down | 1.34E-04 | TMED3 | Up | 3.24E-03 |
AAK1 | Down | 1.61E-04 | MYBL1 | Down | 3.29E-03 |
ME2 | Up | 1.76E-04 | PHEX | Up | 3.81E-03 |
SERPINF1 | Up | 3.00E-04 | UGT8 | Up | 4.98E-03 |
FARP1 | Up | 3.27E-04 | SDC3 | Down | 5.25E-03 |
NUCB2 | Down | 3.58E-04 | SFTPB | Up | 6.06E-03 |
HOMER2 | Up | 5.74E-04 | PEBP1 | Up | 6.34E-03 |
SLC16A6 | Down | 5.75E-04 | LPL | Up | 6.98E-03 |
SYNJ2 | Down | 9.05E-04 | LDOC1 | Up | 7.04E-03 |
SLAMF1 | Down | 9.20E-04 |